< Back to latest news & events

Awards

Managing Intellectual Property IP Stars & Firm Rankings 2021

June 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed.

IP STARS is the leading resource for companies or individuals looking for experienced legal practitioners for contentious and non-contentious IP advice. Managing IP has been covering IP law and practice since 1990.

HGF is delighted to have 14 European attorneys listed in the guide:

Patents

Harry Hutchinson
Dr Chris Moore
Craig Watson
Dr Gary Wilson
Lucy Johnson
Dr Jamie Thomson
Dr Andrew Wells
Dr Susan Keston

Trade Marks

Lee Curtis
Alexander Hagen
David Potter
Pieter de Ruijter
Rigel Moss McGrath

Transactions

Janet Knowles

Click here for more information about MIP IP Stars 2021.

The firm also has 6 ‘Notable practitioners’ listed in the guide:

Dr Jennifer Bailey
Rebecca Field
Dr Nienke Lubben
Dr Jerry Bretherton
Dr Lauris Kemp
Dr Inge Muellejans

The ‘Notable practitioner’ tag is a new recognition (introduced in October 2020) for those noteworthy practitioners who were previously ranked as Rising Stars as well as notable senior practitioners, especially partners.

IP Rising Stars were announced in October 2020. Click here to find 4 HGF’s IP practitioners recognised in this guide.

Firm rankings

United Kingdom (England)

Trade mark prosecution – patent & trade mark attorney firms (2021) – Tier 1
Trade mark contentious – law firms (2021) – notable firm
Patent prosecution (2021) – Tier 2
Patent contentious (2021) – notable firm

United Kingdom (Scotland)

Trade mark prosecution – Highly recommended
Patent prosecution – Highly recommended

The Netherlands

Trade mark prosecution – patent & trade mark attorney firms (2021) – Tier 2

 

Click here for more information on Managing Intellectual Property IP Stars and Firm Rankings.

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article